European Union (EU) Point-of-Care Ultrasound (PoCUS) Device Market Size & Opportunities Analysis - Growth Strategies, Competitiveness, and Forecasts (2026 - 2032)

European Union (EU) Point-of-Care Ultrasound (PoCUS) Device Market Dynamics

Technological Innovation in Miniaturization and AI Integration Are Key Trends

• Innovative developments in computing and electronics, along with transducer technology, have improved the ultrasound technology in the past few years and increased its acceptance into many EU healthcare institutions.
• Many manufacturers of ultrasound devices are developing wireless capabilities using near field communications and/or Bluetooth to enhance the functionality of these devices in acute/critical and emergency care situations.
• Additionally, advancements in semiconductor-based ultrasound technology have made possible the design of hand-held/pocket-size devices capable of producing images equivalent to large cart-based systems.
• Artificial intelligence has become a core enabling technology in PoCUS devices, enhancing image acquisition, interpretation accuracy, and workflow efficiency.
• AI-based applications of PoCUS devices include AI-based measurement tools, real-time image processing/optimization, and AI-guided scanning protocols, which greatly reduce the amount of time required for new users to become proficient on the system.
• Technological innovations have significantly broadened the potential users of these devices beyond traditional specialist groups to include primary care physicians, nurses, and emergency medical professionals, creating an even greater demand for PoCUS devices in the European Union.

Aging Population Is Biggest Driver

• The aging demographics of all European Union member states are driving the rapid increase of the EU PoCUS device market.
• Europe’s ageing population faces a high burden of chronic diseases suited to ultrasound assessment. Over 40% of adults aged ≥65 have two or more chronic conditions.
• Heart failure affects 6–10% of older Europeans, diabetes 20% of those aged 60–79, chronic kidney disease 10–15%, and sarcopenia 10% of adults ≥75.
• Ultrasound is widely used for cardiac, renal, vascular, and musculoskeletal evaluation due to its safety and accessibility.
• Elderly populations are at higher risk for having several chronic diseases which require repeated diagnostic evaluations, and PoCUS devices provide primary care physicians the ability to perform non-invasive assessments of urinary incontinence, abdominal aortic aneurysms, prostate hypertrophy, and cardiac function in an ambulatory care environment.
• Modern PoCUS devices are portable and easy to use to provide healthcare providers the ability to conduct diagnostic evaluations of patients in their offices, nursing homes, and home healthcare environments where the traditional imaging modalities may not be available or easily transportable.
• The trends in the demographics of the elderly populations in the European Region have stimulated the healthcare organizations within the EU to invest in portable diagnostic technologies to provide high-quality healthcare services to the aging population of the EU while minimizing the healthcare expenditures for those services.

European Union (EU) Point-of-Care Ultrasound (PoCUS) Device Market Segmentation Analysis

Device Type Analysis

The diagnostics category holds the largest market share, of 80%, in 2025. The majority of diagnostic PoCUS devices were used in critical care to assess left ventricular systolic function, pericardial effusion, severe mitral regurgitation, pleural effusion, pneumothorax, and pulmonary edema. Emergency department usage of diagnostic devices for bedside and rapid triage assessments also increased the size of the diagnostic category; and the use of PoCUS as an immediate source of diagnostic information for physicians' clinical decisions further increased the size of the diagnostic category.

The therapeutic category will have the highest CAGR, of 7.3%, because of technical developments in ultrasound-guided procedures and growing applications of focused ultrasound therapy. Therapeutic devices now allow for real-time imaging to be integrated with bedside interventions; which has increased both the accuracy of procedural performance and the safety of patients undergoing those procedures, especially when performing nerve blocks, vascular access, and drainage procedures. Also, high-intensity focused ultrasound technology allows for the non-invasive treatment of many medical conditions, providing additional therapeutic uses, thus driving growth in the therapeutic category.

The device types analyzed in this report are:

• Diagnostic Devices (Larger Category)
• Therapeutic Devices (Faster-Growing Category)

Portability Analysis

The trolley/cart-based devices category holds the largest market share, of 55%, in 2025, due to their ability to provide a wide range of imaging capabilities and their long-standing presence in hospitals across the European Union. They provide excellent image quality and they come with a variety of transducers. Some models are equipped with Doppler imaging and 3D/4D imaging. Cart-based systems are the preferred method of providing high-quality images of all parts of the body for radiology departments, ICUs, and ORs. Their strong processing capabilities and large display screens make it possible for physicians to complete complex diagnostic exams quickly.

The compact/handheld devices category will have the highest CAGR, of 7.2%. A significant increase in the number of handheld devices being used in Point-of-Care Settings, Ambulatory Care, and Remote Healthcare Delivery has occurred due to the inclusion of wireless connectivity, cloud-based storage, and the ability to connect directly to a smart phone. The compact design and low cost of these devices have made them very appealing to small healthcare facilities and primary care physicians who want to add to their Diagnostic Capabilities.

The portability analyzed in this report are:

• Trolley/Cart-Based Devices (Larger Category)
• Compact/Handheld Devices (Faster-Growing Category)

Application Analysis

The emergency medicine category holds the largest market share, in 2025, as a result of the critical role PoCUS plays in assessing and triaging patients with acute illness. The use of FAST to evaluate cardiac function and to identify potentially fatal conditions such as pneumothorax and pericardial tamponade has made PoCUS an essential tool in the emergency department. The fact that PoCUS has shown a reduction in time to diagnosis and treatment initiation in Emergency Medicine has promoted the wide-spread adoption of PoCUS in this application area.

The cardiology category will have the highest CAGR, driven by the increasing prevalence of cardiovascular disease and the increasing number of applications for Cardiac PoCUS has contributed to the growth in the Cardiology Application Area. The development of Artificial Intelligence (AI)-driven ejection fraction calculations and automated cardiac measurement capabilities has allowed non-cardiologist healthcare providers to perform reliable cardiac assessments at the bedside. The focus on early detection and monitoring of Heart Failure and the inclusion of PoCUS in Cardiovascular care pathways has contributed to the growth in this Application Area across all EU Member States.

The applications analyzed in this report are:

• Anesthesia
  • Focused cardiac ultrasound
  • Lung ultrasound
  • Airway ultrasound
  • Abdominal ultrasound
  • Chronic Pain
  • Others
• Intensive Care Unit (ICU)
  • Diagnostic
  • Resuscitative
  • Procedure guidance
  • Therapeutic and monitoring
• Emergency Medicine (Largest Category)
• Cardiology (Fastest-Growing Category)
• Vascular and Urology
• Obstetrics and Gynecology (OB/GYN)
• Musculoskeletal
• Others

European Union (EU) Point-of-Care Ultrasound (PoCUS) Device Market Geographical Analysis

Germany Point-of-Care Ultrasound Device Market Size

Germany holds the largest market share, of 20%, in 2025, due to its high level of medical equipment investment, large amount of money spent on healthcare, and increased prevalence of chronic illnesses in need of highly accurate diagnostics. The number of German hospitals and diagnostic facilities using cutting edge medical technology continues to create an ideal environment for PoCUS device adoption. Furthermore, German’s focus on developing new healthcare technologies, as well as their manufacturing industry producing many medical devices, has greatly enhanced the rate of technology adoption, as well as the size of the market.

Germany’s focus on creating efficient and effective healthcare systems has led to increased investment in point-of-care diagnostics that allow patients to receive quicker diagnoses and support better clinical decision-making. The large amount of money allocated to healthcare from Germany's GDP has enabled healthcare organizations to purchase newer medical devices such as PoCUS systems. Germany also contains a variety of prominent medical universities and research institutions that conduct clinical trials and other studies related to POCUS technology. These studies validate the clinical application of POCUS technology, supporting the broad acceptance of POCUS technology by healthcare professionals.

U.K. Point-of-Care Ultrasound Device Market Size

The U.K. will have the highest CAGR, of 7.1%, with the National Health Service (NHS) being a major driver of the adoption of point-of-care ultrasound technologies throughout hospital trusts. The UK's healthcare system recognizes POCUS as a low-cost diagnostic solution that can assist with addressing capacity issues and reducing waiting time for diagnostic tests. The NHS has supported the inclusion of POCUS technology into the emergency department, intensive care unit, and ambulatory care settings with extensive training programs and Clinical Governance Frameworks.

The Recently launched NHS initiatives focus on enhancing diagnostic capability and eliminating health inequality disparities have increased the adoption of POCUS technology in particular in under-served areas of the UK where access to traditional imaging services is limited. Partnerships between healthcare institutions and technology developers have enabled the creation of innovative applications tailored to NHS needs. The UK's strong clinical research infrastructure has helped to develop evidence-based practice guidelines for the use of POCUS technology.

The countries of the market are as follows:

• Germany (Largest Country Market)
• France
• U.K. (Fastest-Growing Country Market)
• Italy
• Spain
• Denmark
• Poland
• Netherlands
• Rest of EU

European Union (EU) Point-of-Care Ultrasound (PoCUS) Device Market Share

The market is semi-consolidated with a mix of large medical equipment manufacturers and specialty ultrasound companies; this creates a highly competitive and innovative environment where manufacturers continually develop products and services. Leading manufacturers have a strong distribution network within all EU countries and are strategically partnered with hospitals and other health care organizations to provide customers with service, support, and brand loyalty.

With rapid advancements in technology, there is a growing number of entrant firms, with a focus on innovative, small, handheld, and/or AI-based solutions for use in point-of-care environments, increasing competitive pressure in the EU POCUS device marketplace. There has been a significant increase in merger and acquisition activity in the industry, driven by larger firms attempting to acquire innovative technologies and broaden the scope of their product lines to remain competitive.

Market leaders have employed several strategies to remain competitive including: investing in R&D to improve image quality and reduce size/weight of devices; partnering with software providers to add AI functionality; collaborating with medical institutions to perform clinical validation studies; and focusing on developing user-friendly interfaces and providing comprehensive training programs to attract users beyond the traditional ultrasound specialist, including general practitioners and allied health professionals.

European Union (EU) Point-of-Care Ultrasound (PoCUS) Device Market News

• In November 2025, Butterfly Network, Inc. launched Compass AI, an enterprise level AI-powered software platform, designed to enable scalable, revenue-generating POCUS programs for European health systems.
• In September 2024, GE HealthCare Technologies Inc. introduced Venue Sprint, a tablet-based POCUS solution, using wireless probe technology, AI-enabled tools and cloud connectivity, to seamlessly connect with existing hospital information systems.
• In February 2024, Butterfly Network, Inc. launched its third generation handheld point-of-care ultrasound system. This includes improved data transfer rate and advanced 3D imaging capabilities available to the European market.
• In October 2023, Razom and Butterfly Network Inc. extended their partnership to deliver 200 Butterfly iQ+ ultrasound units to front-line medical personnel in European conflict zones, demonstrating the effectiveness of POCUS technology in resource-constrained settings.